Intrinsic Value of S&P & Nasdaq Contact Us

Heska Corporation HSKA NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$159.50
+32.9%

Heska Corporation (HSKA) has a consensus analyst rating of Buy, based on 16 analysts covering the stock. Of those, 8 recommend buying, 8 recommend holding, and 0 recommend selling.

The analyst consensus price target for HSKA is $159.50, representing a +32.9% upside from the current price of $119.99. Price targets range from a low of $149.00 to a high of $170.00.

Analyst Consensus — HSKA

Buy
Strong Buy
0
Buy
8
Hold
8
Sell
0
Strong Sell
0
16 analysts
Price Targets
Consensus$159.50
High$170.00
Low$149.00
Median$159.50
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message